Prostate Cancer Clinical Trials

A listing of Prostate Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1155 clinical trials
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy

In the clinical scenario of recurrent prostate cancer (PCa) post local therapy, current standard studies (bone scan and computed tomography) commonly fail to identify the recurrent disease

  • 5 views
  • 24 Mar, 2022
  • 1 location
Focal Radiotherapy for Previously Treated Prostate Cancer Patients

To examine the feasibility, safety and toxicity of focal stereotactic radiation treatment (SBRT) for locally recurrent prostate cancer.

  • 2 views
  • 25 Mar, 2022
  • 1 location
Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

A two arm, multi centric, randomized, open label, parallel, two doses pharmacodynamics study in patients with advanced prostate cancer.

  • 0 views
  • 22 Mar, 2022
  • 1 location
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Primary To evaluate the safety and tolerability of ADXS-504 and to determine the MTD or RP2D.

  • 0 views
  • 20 Oct, 2021
  • 1 location
Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer

PERSEUS1 is an open-label, single arm, phase II trial evaluating the efficacy of Pembrolizumab in metastatic castration resistant prostate cancer (mCRPC) patients (Part A) with a biomarker

measurable disease
enzalutamide
docetaxel
soft tissue disease
direct bilirubin
  • 0 views
  • 24 Jan, 2021
  • 1 location
PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA (PROTRACT)

enzalutamide, and ctDNA fraction ≥2% receives docetaxel) versus clinician's choice of enzalutamide or docetaxel, in subjects with metastatic castration-resistant prostate cancer post abiraterone setting.

gilbert's syndrome
progressive disease
conjugated bilirubin
enzalutamide
docetaxel
  • 0 views
  • 25 Jul, 2022
  • 4 locations
[177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer.

The study aims to evaluate the stability and efficacy after administration of [177Lu]Ludotadipep in patients with metastatic castration resistant prostate cancer (mCRPC), with dose-escalation

  • 19 views
  • 15 Aug, 2021
Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

The objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to subjects and to determine the best administering dose. The study will look at side effects that may happen while taking the combination treatment. A total of …

  • 8 views
  • 10 Mar, 2022
  • 4 locations
IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer

Dose escalation study to evaluate the safety, tolerability and anti-tumor activity of single agent IMU-935 in patients with progressive, metastatic castration resistant prostate cancer (mCRPC

  • 0 views
  • 23 Mar, 2022
  • 1 location
Lu-177-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate

  • 0 views
  • 10 Aug, 2022
  • 20 locations